Influenza A/B Combo Rapid Test Device

Call For Pricing.

Model Number: NH-52213

Brand: Niche Healthcare

The Influenza A+B Rapid Test Device ( Swab ) is a rapid chromatographic immunoassay for the qualitative detection of influenza type A and B nucleoprotein antigens in nasal swabs or throat swabs.This kit is intended to be used as an aid in the diagnosis of influenza A and influenza B virus in nasal swab, throat swabs or nasal aspirate specimens.

 

Description

Catalog No. FLU-6022 Format Device
Specimen Nasal/Throat Certificate CE
Reading Time 15 minutes Test/Kit 40
Storage Temperature 4-30°C Shelf Life 2 Years
Sensitivity >99.9% Specificity >99.9%
Accuracy >99.9% Composition 1.Test device 2. Extraction Tube with Buffer 3. Sterilized Swab 4. Workstation

 

The Influenza A/B Combo Rapid Test Device (Swab) can offer several healthcare benefits in the National Health Service (NHS) or any healthcare system. Here are potential benefits:

  1. Early and Rapid Diagnosis: The rapid test allows for the early and quick diagnosis of influenza A and B viruses using swab samples. Early detection is crucial for initiating appropriate treatment and infection control measures promptly.

  2. Timely Antiviral Treatment: Identifying influenza cases early enables healthcare providers to prescribe antiviral medications promptly. Early antiviral treatment can reduce the severity and duration of symptoms, especially in high-risk populations.

  3. Patient Management: Rapid diagnosis helps healthcare professionals manage patients more effectively by providing timely information on the influenza virus type causing the infection. This allows for tailored treatment and care plans.

  4. Infection Control Measures: Swift identification of influenza cases allows for the implementation of infection control measures to prevent the spread of the virus within healthcare settings and the community.

  5. Resource Optimization: Rapid tests contribute to efficient resource utilization by providing quick and cost-effective diagnostic information, allowing healthcare providers to prioritize and manage influenza cases more effectively.

  6. Reduction of Unnecessary Antibiotic Use: Rapid testing can help reduce unnecessary antibiotic use by distinguishing influenza from bacterial infections. Influenza is a viral infection, and antibiotics are ineffective against viruses.

  7. Public Health Surveillance: Monitoring the prevalence of influenza in the population through rapid testing contributes to public health surveillance efforts. This information helps in predicting and responding to outbreaks, implementing preventive measures, and optimizing vaccine distribution.

  8. Occupational Health: In settings where employees are at risk of influenza exposure (e.g., healthcare workers), rapid testing can aid in quickly identifying and isolating infected individuals, thereby preventing the spread of the virus within the workplace.

  9. Point-of-Care Testing: Rapid tests can be performed at the point of care, providing quick results without the need for sending samples to a laboratory. This expedites decision-making, allowing for immediate treatment initiation and isolation measures if necessary.

 

Infectious Disease Trials

Infectious disease trials are conducted to address various aspects related to the prevention, treatment, and understanding of diseases caused by infectious agents, such as bacteria, viruses, parasites, or fungi. Here are some reasons for conducting infectious disease trials:

  1. Vaccine Development: Trials are crucial for testing the safety and efficacy of new vaccines aimed at preventing infectious diseases. This includes vaccines for viruses like influenza, human papillomavirus (HPV), and emerging threats like COVID-19.
  2. Antiviral and Antibiotic Testing: Clinical trials assess the effectiveness of new antiviral medications or antibiotics in treating infections. This is particularly important in addressing antibiotic resistance and finding alternative treatments.
  3. Understanding Disease Mechanisms: Trials help researchers understand the mechanisms of infectious diseases, including how pathogens spread, evade the immune system, and cause illness.
  4. Global Health Concerns: Trials play a vital role in addressing global health concerns, such as emerging infectious diseases (e.g., Ebola, Zika, COVID-19) and ongoing challenges like malaria, tuberculosis, and HIV.
  5. Public Health Interventions: Trials evaluate the effectiveness of public health interventions, such as strategies for disease prevention, control, and containment.
  6. Drug and Treatment Development: Researchers conduct trials to develop and test new drugs or treatment regimens for infectious diseases, aiming to improve outcomes for affected individuals.
  7. Surveillance and Epidemiology: Clinical trials contribute to surveillance efforts by providing data on disease prevalence, transmission patterns, and the effectiveness of control measures.

Infectious disease trials are essential for advancing our understanding of these diseases, developing effective interventions, and ultimately improving global public health. They contribute significantly to the development of evidence-based strategies for preventing, treating, and managing infectious diseases.

 

Types of Infections

Types of Infections

 

For more information, contact us 01274 965089 or check out our website at www.nicheofficesolutions.co.uk www.nicheofficesolutions.co.uk/niche-nhs

Further clinical information can be found on our blog page: www.nicheofficesolutions.co.uk/category/niche-healthcare-news

For products not found on our online website, please view our Healthcare catalogues: www.nicheofficesolutions.co.uk/healthcare-catalogues

View our Healthcare YouTube videos Playlist

If you have any additional questions, drop us an email at info@nicheofficesolutions.co.uk 

Reviews

There are no reviews yet.

Be the first to review “Influenza A/B Combo Rapid Test Device”